Surrogate end points, health outcomes, and the drug-approval process for the treatment of risk factors for cardiovascular disease

Bruce M. Psaty, Noel S. Weiss, Curt D. Furberg, Thomas D. Koepsell, David S. Siscovick, Frits R. Rosendaal, Nicholas L. Smith, Susan R. Heckbert, Robert C. Kaplan, Danyu Lin, Thomas R. Fleming, Edward H. Wagner